Source: Pharmacy Times articles
The phase 3 REAL8 trial shows once-weekly Sogroya effectively improves growth in children with growth disorders, offering a promising alternative to daily injections.
Read More
by MM360 Staff | May 22, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
The phase 3 REAL8 trial shows once-weekly Sogroya effectively improves growth in children with growth disorders, offering a promising alternative to daily injections.
Read More